OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.08) by 87.5 percent. This is a 85.71 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $163.500 million which beat the analyst consensus estimate of $131.233 million by 24.59 percent. This is a 4.27 percent increase over sales of $156.800 million the same period last year.